Audentes Therapeutics, Inc. - Net Worth and Insider Trading

Audentes Therapeutics, Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Audentes Therapeutics, Inc. owns 1 companies in total, including Taysha Gene Therapies Inc (TSHA) .

Click here to see the complete history of Audentes Therapeutics, Inc.’s form 4 insider trades.

Insider Ownership Summary of Audentes Therapeutics, Inc.

Ticker Comapny Transaction Date Type of Owner
TSHA Taysha Gene Therapies Inc 2022-10-21 10 percent owner

Audentes Therapeutics, Inc. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Audentes Therapeutics, Inc. Ownership Network

Ownership Network List of Audentes Therapeutics, Inc.

No Data

Ownership Network Relation of Audentes Therapeutics, Inc.


Audentes Therapeutics, Inc. Owned Company Details

What does Taysha Gene Therapies Inc do?

Who are the key executives at Taysha Gene Therapies Inc?

Audentes Therapeutics, Inc. is the 10 percent owner of Taysha Gene Therapies Inc. Other key executives at Taysha Gene Therapies Inc include director & 10 percent owner Paul B Manning , Chief Financial Officer Kamran Alam , and 10 percent owner Session R.a. Ii .

Taysha Gene Therapies Inc (TSHA) Insider Trades Summary

Over the past 18 months, Audentes Therapeutics, Inc. made no insider transaction in Taysha Gene Therapies Inc (TSHA). Other recent insider transactions involving Taysha Gene Therapies Inc (TSHA) include a net purchase of 18,066,667 shares made by Paul B Manning , a net sale of 549,095 shares made by Session R.a. Ii , and a net purchase of 777,778 shares made by Stalfort John A Iii .

In summary, during the past 3 months, insiders sold 0 shares of Taysha Gene Therapies Inc (TSHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 582,095 shares of Taysha Gene Therapies Inc (TSHA) were sold and 19,405,000 shares were bought by its insiders, resulting in a net purchase of 18,822,905 shares.

Taysha Gene Therapies Inc (TSHA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Taysha Gene Therapies Inc Insider Transactions

No Available Data

Audentes Therapeutics, Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Audentes Therapeutics, Inc.. You might contact Audentes Therapeutics, Inc. via mailing address: 600 California St., 17th Floor, San Francisco Ca 94108.

Discussions on Audentes Therapeutics, Inc.

No discussions yet.